Please assess the completion status of the following clinical trial:

Trial Title: Investigation of a Sub-Conjunctival Insert

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Be of legal age~* Insulin dependent diabetes requiring daily finger pricking to monitor blood glucose~* Sign written Informed Consent~Exclusion Criteria:~* Inability to follow the protocol schedule~* Participating in another clinical study~* Pregnant or lactating females~* Any ongoing condition that would prevent from proper handling of the instrument (e.g. blindness, strong impaired vision, impaired motor skills)~* Any known hypersensitivity to any of the products to be used in the study, including preservatives etc.~* Malignancies requiring therapy during the study~* Severe chronic diseases e.g. renal failure, liver cirrhosis etc. which may interfere with the conduct or completion of the study~* Poorly controlled diabetes mellitus with prior hemoglobin A1C greater than 10%~* Any ocular disease requiring topical medication besides those permitted by this protocol.~* Ocular or other condition which increase the risk of ocular surgery, e.g. acute or chronic conjunctivitis or blepharitis, corneal disorders, previous eye surgery or eye surgery within the following 12 weeks, coagulation disorders.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort 1 (Type: ACTIVE_COMPARATOR): In the Cohort 1 an uncoated Insert and the photometer version 1 is used. Twelve trial subjects are appointed into 4 subgroups. The difference between these subgroups is the wearing time of the insert.
- Cohort 2 (Type: ACTIVE_COMPARATOR): Cohort 2 consists of 12 trial subjects who are appointed to 2 subgroups. One group will wear the insert for a minimum of 12 month and the other group for a minimum duration of 18 month. In Cohort 2 an improved insert is used. The photometer will be the same than in cohort 1.
- Cohort 3 (Type: ACTIVE_COMPARATOR): Cohort 3 only differs in the used photometer from cohort 2.
- Cohort 4 (Type: ACTIVE_COMPARATOR): Twelve trial subjects are appointed to two subgroups that differ in the minimum wearing duration of the insert (12 month and 18 month). In Cohort 4 a new insert will be tested together with a better photometer.
- Cohort 5 (Type: ACTIVE_COMPARATOR): The difference between Cohort 5 and Cohort 4 is that the best tested insert and the best evaluated photometer will be used.

Based on this trial design, predict the completion outcome and termination type (if applicable).